Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Rajenahally S. Narasegowda"'
Autor:
Rajenahally S. Narasegowda, Ray J. Butcher, B. M. Mohan, H. G. Anilkumar, Hemmige S. Yathirajan
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 63:o33-o35
In the title compound, C12H9F3N2O2, the O atoms participate in hydrogen-bonding interactions with both the NH group and also the CH groups of adjoining molecules.
Autor:
Ray J. Butcher, Hemmige S. Yathirajan, Rajenahally S. Narasegowda, H. G. Anilkumar, Badiadka Narayana
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 62:o5814-o5816
In the title compound, (R,S)-3-ethyl 5-methyl 2-(2-ammonioethoxymethyl)4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate methanesulfonate monohydrate, C20H26ClN2O5+·CH3O3S−·H2O, the cation, anion and water molecu
Autor:
Rajenahally S. Narasegowda, Hemmige S. Yathirajan, Ravindranath S. Rathore, Padmarajaiah Nagaraja, T. Narasimhamurthy, T. Vijay
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o2934-o2936
In the title compound, 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-thione, $C_{15}H_{11}ClN_{2}S$, the central seven-membered diazepinethione ring adopts a boat conformation. The dihedral angle between the planes of the aromatic rings is 63
Autor:
Padmarajaiah Nagaraja, Rajenahally S. Narasegowda, Hemmige S. Yathirajan, Basavegowda Nagaraj, Michael Bolte
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o1193-o1195
The title compound, C22H20ClN3O, ( I), is used as an intermediate for the synthesis of the antihypertensive drug losartan. Bond lengths and angles are unexceptional. The crystal packing is stabilized by one C - H center dot center dot center dot O an
Autor:
T. Narasimhamurthy, Rajenahally S. Narasegowda, Padmarajaiah Nagaraja, Basavegowda Nagaraj, Hemmige S. Yathirajan, Ravindranath S. Rathore
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o356-o358
Supramolecular assembly of the title compound, C12H14ClFN2O, is primarily governed by N-H+...Cl- and C-H...O interactions, and a putative C-H...F interaction. The piperidine ring assumes a chair conformation, with the substituted benzisoxazole ring i
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o179-o181
Valdecoxib, C16H14N2O3S, is a non-steroidal anti-inflammatory drug containing a planar isoxazole heterocycle which is substituted at the C atoms with two aromatic rings and a methyl group. In addition to one molecule of valdecoxib, there is half a
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o176-o178
The title compound, C8H10N3S+·Cl−·H2O, is extensively used as a spectrophotometric reagent for the determination of pharmaceutical compounds, vitamins and environmental samples.
Autor:
Rajenahally S. Narasegowda, Sukanta Mondal, Basavegowda Nagaraj, Hemmige S. Yathirajan, T. Narasimhamurthy, Ravindranath S. Rathore
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 61:o151-o153
The molecular structure of the title compound, $C_{9}H_{16}O_{4}$, is described by a trans-planar configuration of the propyl chains. The molecule has an approximate pseudo-twofold rotation axis in the crystal structure. The molecules are interconnec
Autor:
Hemmige S. Yathirajan, B. Prabhuswamy, Basavegowda Nagaraj, Santhosh L. Gaonkar, Michael Bolte, Rajenahally S. Narasegowda, Padmarajaiah Nagaraja
Publikováno v:
Acta Crystallographica Section E Structure Reports Online. 60:o2160-o2162
The title compound {systematic name: methyl 2-[(2′-cyanobiphenyl-4-yl)methylammonio]-3-methylbutanoate chloride}, C20H23N2O2+·Cl−, is a key intermediate in the synthesis of valsartan. It crystallizes with two ion pairs in the asymmetri
Autor:
Ravindranath S. Rathore, Rajenahally S. Narasegowda, Daniel E. Lynch, Hemmige S. Yathirajan, T. Narasimhamurthy
Publikováno v:
Acta crystallographica. Section C, Crystal structure communications. 62(Pt 5)
In 1-cyclohexyl-6,6,8a-trimethyl-3a,6,7,8a-tetrahydro-1H-1-benzofuro[2,3-b]pyrrole-2,4(3H,5H)-dione, C19H27NO3, (I), and the isomorphous compounds 6,6,8a-trimethyl-1-phenyl-3a,6,7,8a-tetrahydro-1H-1-benzofuro[2,3-b]pyrrole-2,4(3H,5H)-dione, C19